Current management of breast cancer

American Family Physician

Volumn 53, Issue 2, 1996, Pages 657-665

  Phillips, D Melessa ^a   Balducci, Lodovico ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINOGLUTETHIMIDE; ANTINEOPLASTIC AGENT; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYCLOPHOSPHAMIDE; DIURETIC AGENT; DOXORUBICIN; ESTROGEN; ESTROGEN RECEPTOR; FLUOROURACIL; GESTAGEN; GONADORELIN DERIVATIVE; HORMONE; LIVER ENZYME; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; PACLITAXEL; SOMATOMEDIN C; TAMOXIFEN; TAMOXIFEN CITRATE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERCALCEMIA; LYMPHADENECTOMY; MALE; MAMMOGRAPHY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; SOMNOLENCE; THORAX RADIOGRAPHY;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; NEOPLASM STAGING; PROGNOSIS;

EID: 0030059053     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993;43(1):7-26.
2. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: DeVita VT Jr, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 4th ed. Philadelphia: Lippincott, 1993;1264-332
3. Kinne DW, Kopans DB. Physical examination and mammography in the diagnosis of breast disease. In: Harris JR, et al., eds. Breast diseases. 2d ed. Philadelphia: Lippincott, 1991:81-107.
4. Carbonne PP, Jordan VC, Bonadonna G. Neoplasms of the breast. In: Calabresi P, Schein PS, eds. Medical oncology, basic principles and clinical management of cancer. 2d ed. New York: McGraw-Hill, 1993:819-49.
5. Hammond S, Keyhani-Rofagha S, O'Toole RV. Statistical analysis of fine needle aspiration cytology of the breast. A review of 678 cases plus 4,265 cases from the literature. Acta Cytol 1987;31:276-80.
6. Balducci L, Schapira DV, Cox CE, Greenberg HM, Lyman GH. Breast cancer of the older woman: an annotated review. J Am Geriatr Soc 1991;39:1113-23.
7. al-Jarallah MA, Behbehani AE, el-Nass SA, Temim L, Ebraheem AK, Ali MA, et al. Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma. Eur J Surg Oncol 1993;19:74-9.
8. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980;45:2917-24.
9. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
10. Wong M, Gruber J. Viral interactions with the p53 gene in human cancer: NCI workshop. J Natl Cancer Inst 1994;86:177-82.
11. Thor AD, Moore DH 2d, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-55.
12. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
13. Senie RT, Rosen PP, Rhodes P, Lesser ML. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann Intern Med 1991;115:337-42.
14. Badwe RA, Gregory WM, Chaudary MA, Richards MA, Bentley AE, Rubens RD, et al. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet 1991;337:1261-4.
15. Figueroa JA, Yee D, McGuire WL. Prognostic indicators in early breast cancer. Am J Med Sci 1993; 305:176-82.
16. Glick JH, Gelber RD, Goldhirsch A, Senn HJ. Meeting highlights: adjuvant therapy for primary breast cancer. J Natl Cancer Inst 1992;84:1479-85
17. Clark GM, McGuire WL. Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Res 1991;51:944-8.
18. McGuire WL, Tandon AK, Allred DC, Chamness GC, Clark GM. How to use prognostic factors in axillary node-negative breast cancer patients J Natl Cancer Inst 1990;82:1006-15.
19. Parker LM, Boyages J, Eberlem TJ. Inflammatory carcinoma of the breast. In: Harris JR, et al, eds. Breast diseases. 2d ed. Philadelphia: Lippincott, 1991:775-82.
20. Hietanen P Chest radiography in the follow-up of breast cancer. Acta Radiol Oncol 1986;25:15-8.
21. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
22. Kiebert GM, de Haes JC, van de Velde CJ. The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol 1991;9:1059-70.
23. Silliman RA, Balducci L, Goodwin JS, Holmes FF, Leventhal EA. Breast cancer care in old age: what we know, don't know, and do. J Natl Cancer Inst 1993;85:190-9.
24. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328:1587-91.
25. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
26. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. Lancet 1992; 339:71-85.
27. Henderson IC. Adjuvant systemic therapy of early breast cancer. In: Harris JR, et al, eds. Breast diseases. 2d ed. Philadelphia: Lippincott, 1991:427-86.
28. Gelber RD, Goldhirsch A, Cavalli F. Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. Ann Intern Med 1991;114:621-8.
29. Jordan VC. Overview from the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer. J Natl Cancer Inst 1992;84:231-4.
30. Bates T, Riley DL, Houghton J, Fallowfield L, Baum M. Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg 1991;78:591-4.
31. Schapira DV, Urban N. A minimalist policy for breast cancer surveillance. JAMA 1991;265:380-2.
32. Hortobagyi GN. Comprehensive management of locally advanced breast cancer. Cancer 1990;66(6 Suppl):1387-91.
33. Mourali N, Tabbane F, Muenz LR, Behi J, Ben Moussa F, Jaziri M, et al. Ten-year results utilizing chemotherapy as primary treatment in nonmetastatic, rapidly progressing breast cancer. Cancer Invest 1993;11:363-70.
34. Henderson IC. Principles in the management of metastatic disease: endocrine therapy of metastatic breast cancer. In: Harris JR, et al, eds. Breast diseases. 2d ed. Philadelphia: Lippincott, 1991;559-604.
35. Henderson IC. Chemotherapy for metastatic disease. In: Harris JR, et al, eds. Breast diseases. 2d ed. Philadelphia: Lippincott, 1991;604-64.
36. Guinee VF, Olsson H, Moller T, Shallenberger RC, van den Blink JW, Peter Z, et al. The prognosis of breast cancer in males. A report of 335 cases. Cancer 1993;71:154-61.